{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:22:58Z","timestamp":1788909778467,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neuint.2025.106090","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:53:00Z","timestamp":1764229980000},"page":"106090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A novel GSK3\u03b2 inhibitor ameliorates tau aggregation and neuroinflammation in Alzheimer's disease"],"prefix":"10.1016","volume":"192","author":[{"given":"Xin-Yue","family":"Ning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Meng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Zhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-He","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Hua","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Chun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2025.106090_bib1","article-title":"MCPIP1 alleviates depressive-like behaviors in mice by inhibiting the TLR4\/TRAF6\/NF-kappaB pathway to suppress neuroinflammation","volume":"29","author":"An","year":"2024","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuint.2025.106090_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuint.2025.106090_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuint.2025.106090_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118475","article-title":"GSK3beta inhibition promotes synaptogenesis in drosophila and Mammalian neurons","volume":"10","author":"Cuesto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2025.106090_bib5","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/hmg\/7.11.1825","article-title":"Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism","volume":"7","author":"Dumanchin","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuint.2025.106090_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trci.2016.06.002","article-title":"First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease","volume":"2","author":"Ferrero","year":"2016","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.neuint.2025.106090_bib7","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.2174\/0929867329666220216113517","article-title":"Glycogen synthase kinase 3beta involvement in neuroinflammation and neurodegenerative diseases","volume":"29","author":"Gianferrara","year":"2022","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuint.2025.106090_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.neuint.2012.07.003","article-title":"GSK-3 mediates the release of IL-1 beta, TNF-alpha and IL-10 from cortical glia","volume":"61","author":"Green","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2025.106090_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2025.106090_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","article-title":"Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17","volume":"393","author":"Hutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2025.106090_bib12","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease","volume":"345","author":"in t' Veld","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2025.106090_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","article-title":"Microglia-specific localisation of a novel calcium binding protein, Iba1","volume":"57","author":"Ito","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuint.2025.106090_bib14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","article-title":"Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain","volume":"32","author":"Ito","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2025.106090_bib15","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuint.2025.106090_bib16","article-title":"Modeling of tau-mediated synaptic and neuronal degeneration in Alzheimer's disease","volume":"2010","author":"Jaworski","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.neuint.2025.106090_bib17","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1038\/s41598-023-32798-9","article-title":"LPS induces microglial activation and GABAergic synaptic deficits in the hippocampus accompanied by prolonged cognitive impairment","volume":"13","author":"Jung","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106090_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","article-title":"GSK-3: functional insights from cell biology and animal models","volume":"4","author":"Kaidanovich-Beilin","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuint.2025.106090_bib19","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12035-014-8699-4","article-title":"Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer's disease therapeutic application","volume":"50","author":"Kamat","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuint.2025.106090_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2025.106090_bib21","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.3233\/JAD-142025","article-title":"Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function","volume":"44","author":"Kettunen","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neuint.2025.106090_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuint.2025.106090_bib23","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd.2017.155","article-title":"Tau-based therapies in neurodegeneration: opportunities and challenges","volume":"16","author":"Li","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuint.2025.106090_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fphar.2018.00346","article-title":"Analogous beta-Carboline alkaloids harmaline and harmine ameliorate scopolamine-induced cognition dysfunction by attenuating acetylcholinesterase activity, oxidative stress, and inflammation in mice","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106090_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109525","article-title":"An inhibitor with GSK3beta and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease","volume":"232","author":"Liu","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2025.106090_bib26","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-023-02357-w","article-title":"Silencing tau to treat early Alzheimer's disease","volume":"29","author":"Ljubenkov","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuint.2025.106090_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.molcel.2006.10.009","article-title":"A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation","volume":"24","author":"Lochhead","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.neuint.2025.106090_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.neuint.2025.106090_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/01677063.2011.626471","article-title":"Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease","volume":"25","author":"Marcus","year":"2011","journal-title":"J. Neurogenet."},{"key":"10.1016\/j.neuint.2025.106090_bib30","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni1221","article-title":"Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3","volume":"6","author":"Martin","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.neuint.2025.106090_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s40364-024-00691-w","article-title":"FBXL16: a new regulator of neuroinflammation and cognition in Alzheimer's disease through the ubiquitination-dependent degradation of amyloid precursor protein","volume":"12","author":"Qu","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.neuint.2025.106090_bib32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejphar.2013.04.033","article-title":"Neuroprotective effect of curcumin on okadaic acid induced memory impairment in mice","volume":"715","author":"Rajasekar","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2025.106090_bib33","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","article-title":"Microglia-Mediated synapse loss in Alzheimer's Disease","volume":"38","author":"Rajendran","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2025.106090_bib34","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1172\/JCI90606","article-title":"Microglia in Alzheimer's disease","volume":"127","author":"Sarlus","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.neuint.2025.106090_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.cb.10.110194.002105","article-title":"Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease","volume":"10","author":"Selkoe","year":"1994","journal-title":"Annu. Rev. Cell Biol."},{"key":"10.1016\/j.neuint.2025.106090_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27175481","article-title":"Lipopolysaccharide-Induced model of neuroinflammation: mechanisms of action, research application and future directions for its use","volume":"27","author":"Skrzypczak-Wiercioch","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.neuint.2025.106090_bib37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s41374-019-0197-x","article-title":"MAPT mutations, tauopathy, and mechanisms of neurodegeneration","volume":"99","author":"Strang","year":"2019","journal-title":"Lab. Invest."},{"issue":"Pt 1","key":"10.1016\/j.neuint.2025.106090_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj2960015","article-title":"Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling","volume":"296","author":"Sutherland","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuint.2025.106090_bib39","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2018.12.005","article-title":"It's all about tau","volume":"175","author":"Tapia-Rojas","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2025.106090_bib41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2025.106090_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2025.106090_bib43","article-title":"The effects of microglia-associated neuroinflammation on alzheimer's disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuint.2025.106090_bib44","doi-asserted-by":"crossref","unstructured":"Wenjie Liu, L.W., Zeng, Xi, Chen, Huanhua, Ning, Xinyue, Sun, Xiaoyu, Xuan, Wenqiang, Ying, Hao, Jia, Hongli, Li, Zhenshu, Xu, Zonghe, Li, Xinyu, Xu, Zihua, Liu, Wenwu, Zhao, Qingchun, Shuang, Hao, 2025. Discovery of Novel Harmine Derivatives as Potent, Selective, and Brain Permeable GSK3\u03b2 Inhibitors with Effective In Vivo anti-AD Activity. Eur. J. Med. Chem.118389.","DOI":"10.1016\/j.ejmech.2025.118389"},{"key":"10.1016\/j.neuint.2025.106090_bib50","series-title":"The top 10 causes of death","article-title":"Global status report on the public health response to dementia: \u0435xecutive summary, 2021","year":"2024"},{"key":"10.1016\/j.neuint.2025.106090_bib45","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/intimm\/dxh316","article-title":"Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages","volume":"17","author":"Yang","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.neuint.2025.106090_bib46","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.stem.2023.08.011","article-title":"A cell therapy approach to restore microglial Trem2 function in a mouse model of alzheimer's disease","volume":"30","author":"Yoo","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.neuint.2025.106090_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14818","article-title":"GSK3: a potential target and pending issues for treatment of alzheimer's disease","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuint.2025.106090_bib48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40035-016-0054-4","article-title":"The dual roles of cytokines in alzheimer's disease: update on interleukins, TNF-alpha, TGF-Beta and IFN-Gamma","volume":"5","author":"Zheng","year":"2016","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.neuint.2025.106090_bib49","doi-asserted-by":"crossref","first-page":"11558","DOI":"10.1039\/C8CC06897F","article-title":"Synthesis and evaluation of pyrazine and quinoxaline fluorophores for in vivo detection of cerebral tau tangles in Alzheimer's models","volume":"54","author":"Zhu","year":"2018","journal-title":"Chem. Commun."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:02:02Z","timestamp":1767895322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018625001639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"alternative-id":["S0197018625001639"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106090","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel GSK3\u03b2 inhibitor ameliorates tau aggregation and neuroinflammation in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106090"}}